December 23, 2014
Bethel Nutritional Consulting, Inc. Recalls B-Lipo Capsules Due to Undeclared Drug Ingredient
The Missouri Department of Health and Senior Services received information regarding a recall of B-Lipo Capsules. The product was found to contain Lorcaserin, a controlled substance used for weight loss.
Adverse health consequences associated with taking Lorcaserin range from difficulty thinking, hallucinations, and feeling of intense excitement to changes in blood sugar and heart rate. More serious adverse events, which may be life-threatening, include damage to the heart valve, or serotonin syndrome particularly if Lipo-B is taken with other medications that work similarly. Excessive levels of serotonin can cause symptoms that range from mild (shivering and diarrhea) to severe (muscle stiffness, fever, and seizures). Severe serotonin syndrome can be fatal if not treated.
B-Lipo Capsules are marketed as a Natural Herbal Supplement for Weight Loss. B-Lipo burgundy and white Capsules are packaged in white plastic bottles containing 30 Capsules per bottle, and labeled with Lot # 20213 EXP DATE 12/22/2016, and bar code 160126 417509.
The product was sold directly to individual customers in our New York City sales office and to consumers online at www.bethel30.com.
The full recall can be found at: www.fda.gov/Safety/Recalls/ucm427657.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.